As NCI-MATCH Winds Down, Cancer Research Community Takes Stock of Lessons Learned

Multiple successor trials are in the works based on hits, misses and overall knowledge gained from one of the first precision medicine platform trials.

Related Keywords

Massachusetts ,United States ,Barack Obama ,Peter Odwyer ,Novarti Tafinlar ,Razelle Kurzrock ,Bristol Myers Squibb Opdivo ,Merck Keytruda ,Keith Flaherty ,Lyndsay Harris ,Yale University ,College Of Wisconsin Cancer Center ,Drug Administration ,Md Anderson Cancer Center ,Cancer Research Group ,Molecular Characterization Laboratory Mocha ,Frederick Laboratory ,Frederick Laboratory For Cancer ,Precision Medicine Initiative ,Cancer Research Network ,Therapy Choice ,Research Group ,Bristol Myers Squibb ,Petero Dwyer ,Penn Medicine ,Molecular Characterization Laboratory ,Cancer Genome Atlas ,Cancer Center ,Massachusetts General Hospital ,Medical College ,Wisconsin Cancer Center ,Research Network ,